Research on women’s health highlights how biological sex, hormones, and gendered life experiences shape disease risk, diagnosis, and treatment.

Hormonal shifts across the lifespan influence cardiovascular health, metabolic function, bone integrity, and brain aging. Estrogen appears protective for blood vessels and lipid profiles; its decline around menopause is associated with rising blood pressure, unfavorable cholesterol changes, and increased heart disease risk. Studies suggest that cardiovascular symptoms and progression can differ in women, with more microvascular disease and atypical chest pain, leading to underdiagnosis.

In metabolism and obesity, women tend to store more subcutaneous fat, while men accumulate more visceral fat, which is more strongly linked to diabetes and heart disease. However, after menopause women’s visceral fat and metabolic risk often increase. Research points to sex specific responses to diet and physical activity, as well as differing patterns of nonalcoholic fatty liver disease and type 2 diabetes.

Bone health is strongly affected by estrogen. Women reach peak bone mass earlier and lose bone more rapidly after menopause, contributing to a higher prevalence of osteoporosis and fractures. Nutritional intake, weight bearing exercise, and medications that modulate bone turnover are central preventive strategies.

In brain and mental health, sex differences appear in the prevalence, timing, and presentation of conditions such as depression, anxiety, and neurodegenerative diseases. Hormones, immune function, and social stressors all contribute. There is growing evidence that diagnostic criteria, clinical trial design, and treatment guidelines must account for sex and gender to avoid misdiagnosis, suboptimal therapy, and health inequities.